# To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

> **NCT01420328** · NA · COMPLETED · sponsor: **University at Buffalo** · enrollment: 20 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DRUG:** Vytorin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01420328
- **Lead sponsor:** University at Buffalo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-01
- **Primary completion:** 2015-07-01
- **Final completion:** 2016-07-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01420328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01420328, "To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01420328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*